• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-氨基苯并恶唑取代香豆素作为强效和选择性的肿瘤相关碳酸酐酶抑制剂。

2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases.

机构信息

Facultad de Ciencias Químicas, Ciudad Universitaria, Benemérita Universidad Autónoma de Puebla, Puebla, México.

BioLab, Instituto Universitario de Bio-Orgánica "Antonio González" (IUBO-AG), Universidad de La Laguna, La Laguna, Spain.

出版信息

J Enzyme Inhib Med Chem. 2022 Dec;37(1):168-177. doi: 10.1080/14756366.2021.1998026.

DOI:10.1080/14756366.2021.1998026
PMID:34894971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8667885/
Abstract

We have carried out the design, synthesis, and evaluation of a small library of 2-aminobenzoxazole-appended coumarins as novel inhibitors of tumour-related CAs IX and XII. Substituents on C-3 and/or C-4 positions of the coumarin scaffold, and on the benzoxazole moiety, together with the length of the linker connecting both units were modified to obtain useful structure-activity relationships. CA inhibition studies revealed a good selectivity towards tumour-associated CAs IX and XII ( within the mid-nanomolar range in most of the cases) in comparison with CAs I, II, IV, and VII ( > 10 µM); CA IX was found to be slightly more sensitive towards structural changes. Docking calculations suggested that the coumarin scaffold might act as a prodrug, binding to the CAs in its hydrolysed form, which is in turn obtained due to the esterase activity of CAs. An increase of the tether length and of the substituents steric hindrance was found to be detrimental to antiproliferative activities. Incorporation of a chlorine atom on C-3 of the coumarin moiety achieved the strongest antiproliferative agent, with activities within the low micromolar range for the panel of tumour cell lines tested.

摘要

我们设计、合成并评价了一个包含 2-氨基苯并恶唑取代香豆素的小分子库,作为新型肿瘤相关 CAIX 和 CAXII 的抑制剂。香豆素骨架的 C-3 和/或 C-4 位以及苯并恶唑部分上的取代基,以及连接两个单元的连接链的长度都进行了修饰,以获得有用的构效关系。CA 抑制研究显示,与 CA I、II、IV 和 VII(>10μM)相比,这些化合物对肿瘤相关的 CAIX 和 CAXII 具有较好的选择性(大多数情况下为中纳摩尔范围);CAIX 对结构变化的敏感性略高。对接计算表明,香豆素骨架可能作为前药起作用,以其水解形式与 CA 结合,这是由于 CA 的酯酶活性所致。增加连接链的长度和取代基的空间位阻被发现对增殖活性有害。在香豆素部分的 C-3 上引入氯原子可获得最强的增殖抑制剂,在所测试的肿瘤细胞系中,其活性处于低微摩尔范围内。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/5f9ef311340e/IENZ_A_1998026_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/3080c242049e/IENZ_A_1998026_UF0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/e52eaf555ff1/IENZ_A_1998026_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/1f5916e6a972/IENZ_A_1998026_SCH0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/586e842ed8be/IENZ_A_1998026_SCH0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/3e5163b57996/IENZ_A_1998026_SCH0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/a10faee9253b/IENZ_A_1998026_SCH0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/95d7f5ba519b/IENZ_A_1998026_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/5f9ef311340e/IENZ_A_1998026_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/3080c242049e/IENZ_A_1998026_UF0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/e52eaf555ff1/IENZ_A_1998026_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/1f5916e6a972/IENZ_A_1998026_SCH0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/586e842ed8be/IENZ_A_1998026_SCH0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/3e5163b57996/IENZ_A_1998026_SCH0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/a10faee9253b/IENZ_A_1998026_SCH0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/95d7f5ba519b/IENZ_A_1998026_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c0/8667885/5f9ef311340e/IENZ_A_1998026_F0003_C.jpg

相似文献

1
2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases.2-氨基苯并恶唑取代香豆素作为强效和选择性的肿瘤相关碳酸酐酶抑制剂。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):168-177. doi: 10.1080/14756366.2021.1998026.
2
Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma.双香豆素的合成、生物活性及多尺度分子模拟研究作为选择性碳酸酐酶 IX 和 XII 抑制剂,对肝癌具有有效的细胞毒性。
Bioorg Chem. 2019 Jun;87:838-850. doi: 10.1016/j.bioorg.2019.03.003. Epub 2019 Mar 7.
3
Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII.关于香豆素导致色烯并[4,3-c]吡唑-4-酮和吡喃并[4,3-c]吡唑-4-酮的结构研究:肿瘤相关碳酸酐rase 同工酶 IX 和 XII 设计的新骨架。
Eur J Med Chem. 2018 Feb 25;146:47-59. doi: 10.1016/j.ejmech.2018.01.033. Epub 2018 Jan 12.
4
Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent.研究 3-磺胺酰基香豆素对人碳酸酐酶 IX 和 XII 同工型以及癌细胞的抑制作用,发现了 2-氧代-2H-苯并[h]色烯-3-磺酰胺 - 一种新的半胱天冬酶激活的促凋亡剂。
Eur J Med Chem. 2021 Oct 15;222:113589. doi: 10.1016/j.ejmech.2021.113589. Epub 2021 Jun 10.
5
Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors.新型 4,7-二取代香豆素的合成及作为选择性肿瘤相关碳酸酐酶 IX 和 XII 抑制剂的生物评价。
Bioorg Med Chem Lett. 2021 May 1;39:127877. doi: 10.1016/j.bmcl.2021.127877. Epub 2021 Feb 26.
6
Conformationally Restricted Glycoconjugates Derived from Arylsulfonamides and Coumarins: New Families of Tumour-Associated Carbonic Anhydrase Inhibitors.基于芳基磺酰胺和香豆素的构象受限糖缀合物:新型肿瘤相关碳酸酐酶抑制剂家族。
Int J Mol Sci. 2023 May 28;24(11):9401. doi: 10.3390/ijms24119401.
7
Mitigating the resistance of MCF-7 cancer cells to Doxorubicin under hypoxic conditions with novel coumarin based carbonic anhydrase IX and XII inhibitors.用新型香豆素类碳酸酐酶 IX 和 XII 抑制剂减轻 MCF-7 癌细胞在缺氧条件下对阿霉素的耐药性。
Bioorg Chem. 2024 Nov;152:107759. doi: 10.1016/j.bioorg.2024.107759. Epub 2024 Aug 26.
8
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.新型香豆素类化合物对人碳酸酐酶 IX 和 XII 的选择性抑制作用及结构研究。
Eur J Med Chem. 2018 Jan 1;143:276-282. doi: 10.1016/j.ejmech.2017.11.061. Epub 2017 Nov 23.
9
Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives.香豆素和补骨脂素衍生物对碳酸酐酶 IX 和 XII 的选择性抑制。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):685-692. doi: 10.1080/14756366.2021.1887171.
10
Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX.新型香豆素和苯并香豆素作为肿瘤相关碳酸酐酶 IX 的同工型选择性抑制剂。
J Enzyme Inhib Med Chem. 2014 Apr;29(2):292-6. doi: 10.3109/14756366.2013.777334. Epub 2013 Mar 14.

引用本文的文献

1
Microwave-enhanced additive-free C-H amination of benzoxazoles catalysed by supported copper.负载型铜催化的苯并恶唑的微波增强无添加剂C-H胺化反应
Beilstein J Org Chem. 2025 Jul 15;21:1462-1476. doi: 10.3762/bjoc.21.108. eCollection 2025.
2
Conformationally Restricted Glycoconjugates Derived from Arylsulfonamides and Coumarins: New Families of Tumour-Associated Carbonic Anhydrase Inhibitors.基于芳基磺酰胺和香豆素的构象受限糖缀合物:新型肿瘤相关碳酸酐酶抑制剂家族。
Int J Mol Sci. 2023 May 28;24(11):9401. doi: 10.3390/ijms24119401.
3
Inhibition studies of the protozoan α-carbonic anhydrase from with phenols.

本文引用的文献

1
Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders.多靶点靶向策略涉及碳酸酐酶抑制剂:针对多种疾病的杂合药物。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1702-1714. doi: 10.1080/14756366.2021.1945049.
2
Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agents.设计、合成及 3,7-取代香豆素衍生物作为多功能阿尔茨海默病药物的评估。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1607-1621. doi: 10.1080/14756366.2021.1913137.
3
Deciphering the detailed structure-activity relationship of coumarins as Monoamine oxidase enzyme inhibitors-An updated review.
用酚类物质对原生动物α-碳酸酐酶的抑制研究。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2417-2422. doi: 10.1080/14756366.2022.2119965.
4
Synthesis, Biological Evaluation, and Studies of Novel Coumarin-Based 4,5-pyrano[3,2-]chromenes as Potent β-Glucuronidase and Carbonic Anhydrase Inhibitors.新型香豆素基4,5-吡喃并[3,2-]色烯作为强效β-葡萄糖醛酸酶和碳酸酐酶抑制剂的合成、生物学评价及研究
ACS Omega. 2022 Aug 4;7(32):28605-28617. doi: 10.1021/acsomega.2c03528. eCollection 2022 Aug 16.
5
Squaramide-Tethered Sulfonamides and Coumarins: Synthesis, Inhibition of Tumor-Associated CAs IX and XII and Docking Simulations.巯基酰胺-连接的磺酰胺和香豆素:合成、抑制肿瘤相关 CAIX 和 CAXII 及对接模拟。
Int J Mol Sci. 2022 Jul 12;23(14):7685. doi: 10.3390/ijms23147685.
解析香豆素类化合物作为单胺氧化酶抑制剂的详细构效关系:最新综述。
Chem Biol Drug Des. 2021 Oct;98(4):655-673. doi: 10.1111/cbdd.13919. Epub 2021 Jul 26.
4
Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives.香豆素和补骨脂素衍生物对碳酸酐酶 IX 和 XII 的选择性抑制。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):685-692. doi: 10.1080/14756366.2021.1887171.
5
Synthesis and anti-rheumatoid arthritis activities of 3-(4-aminophenyl)-coumarin derivatives.3-(4-氨基苯基)-香豆素衍生物的合成及抗类风湿关节炎活性。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):450-461. doi: 10.1080/14756366.2021.1873978.
6
A Review on Anti-Tumor Mechanisms of Coumarins.香豆素类化合物抗肿瘤机制综述
Front Oncol. 2020 Dec 4;10:592853. doi: 10.3389/fonc.2020.592853. eCollection 2020.
7
Elucidating the role of metal ions in carbonic anhydrase catalysis.阐明金属离子在碳酸酐酶催化中的作用。
Nat Commun. 2020 Sep 11;11(1):4557. doi: 10.1038/s41467-020-18425-5.
8
Recent advancements of coumarin-based anticancer agents: An up-to-date review.香豆素类抗癌剂的最新进展:最新综述。
Bioorg Chem. 2020 Oct;103:104163. doi: 10.1016/j.bioorg.2020.104163. Epub 2020 Aug 26.
9
Coumarin carbonic anhydrase inhibitors from natural sources.天然来源的香豆素碳酸酐酶抑制剂。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1462-1470. doi: 10.1080/14756366.2020.1788009.
10
Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents.抑制碳酸酐酶 IX 和 XII 的活性作为开发新型抗癌药物的候选物选择标准。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1555-1561. doi: 10.1080/14756366.2020.1801674.